Skip to main content

Table 2 Assessment of Liver Biochemistry and Lipids

From: Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study

  Control PBC (0th week) TN sham-TN
before after before after
AST (U/L, mean ± SD) 23.30 ± 4.57 37.70 ± 12.90^ 37.10 ± 14.71 36.50 ± 16.71 34.70 ± 14.97 36.80 ± 19.62
ALT (U/L, mean ± SD) 16.30 ± 6.41 47.30 ± 23.16^ 46.40 ± 27.35 38.30 ± 25.17 38.80 ± 24.49 42.70 ± 35.24
ALP (U/L, mean ± SD) 62.00 ± 15.36 204.40 ± 94.51^ 191.40 ± 70.42 148.50 ± 49.66* 178.40 ± 99.61 165.30 ± 65.75
γ-GT (U/L, mean ± SD, Median50(M25 ~ M75)) 22.20 ± 8.53 287.60 ± 176.38^ 217.00 (126.75 ~ 418.50) 138.50 (102.50 ~ 302.25)* 165.00 (111.50 ~ 348.25) 151.50 (91.75 ~ 314.75)
TC (mmol/l, mean ± SD) 4.58 ± 0.53 5.87 ± 1.59^ 6.01 ± 1.27 5.94 ± 1.68 5.78 ± 1.83 6.05 ± 1.25
TG (mmol/l, mean ± SD) 1.06 ± 0.50 1.32 ± 0.66 1.43 ± 0.69 1.42 ± 0.37 1.28 ± 0.4 1.28 ± 0.45